Asangi R. Kumarapeli
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Researcher
Also affiliated: Women & Children's Hospital of Buffalo (2013); Summa Health System (2015–2025); National Institutes of Health (2005); University of South Dakota (2004–2015); University of Washington (2015); University of Sioux Falls (2005–2006); Cardiovascular Institute of the South (2008); Avera Health (2005); Yale University (2010); National Institute for Health and Care Research (2005); South Dakota Foundation for Medical Care (2005); National Eye Institute (2005); Center for Systems Biology (2010); University at Buffalo, State University of New York (2013); University of Pennsylvania (2008–2009); Temple University (2008); Guangzhou Medical University (2005)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Asangi R. Kumarapeli's research focuses on disease mechanisms, particularly in the context of cardiac function and viral infections. Kumarapeli has investigated the role of specific genes, such as the M2 gene, in reovirus-induced myocarditis, utilizing mouse models. This work contributes to understanding the molecular underpinnings of heart disease and viral pathogenesis. Kumarapeli's publication record also includes studies on various other medical conditions, such as mammary adenoid cystic carcinoma, granular cell tumors, and pulmonary manifestations of Crohn's disease. Collaborations include work with Karl W. Boehme, Marjan Boerma, Vijayalakshmi Sridharan, and Amairani Paredes, all from the University of Arkansas for Medical Sciences, with shared publications indicating active research partnerships. Kumarapeli's scholarly output is reflected in an h-index of 12 and 933 citations across 42 publications.
Metrics
- h-index: 12
- Publications: 42
- Citations: 936
Selected Publications
-
Class A scavenger receptors promote tumor progression and induce a unique macrophage phenotype in a mouse model of spontaneous breast cancer (2026)
-
Clinicopathologic Predictors of Clinical Outcomes in Mammary Adenoid Cystic Carcinoma: A Multi-institutional Study (2023)
-
Abstract 11421: The M2 Gene is a Determinant of Reovirus-Induced Myocarditis (2021)
-
The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis (2021)
-
The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis (2021)
-
Macrophage Class A Scavenger Receptors Bind Tumor‐Associated Carbohydrate Antigens and Promote Breast Cancer Growth and Metastases in Mice (2020)
-
Dantrolene Attenuates Cardiotoxicity of Doxorubicin Without Reducing its Antitumor Efficacy in a Breast Cancer Model (2020)
-
Cytology of Normal Central Nervous System: A Systematic Evaluation of Cytologic Preparation and Staining Methods with Emphasis on Potential Diagnostic Pitfalls (2018)
-
Short-Duration Rapid Chilling of Mastectomy Specimens Does Not Interfere With Breast Cancer Biomarker and Molecular Testing (2018)
-
Metastatic melanoma with dedifferentiation and extensive rhabdomyosarcomatous heterologous component (2018)
-
Utility of autopsy brain imprint and squash cytology for detection of lymphoma/leukemia emboli in select patients presenting with rapid decline in mental status (2018)
-
Breast Biomarker Immunocytochemistry (2017)
-
Reducing doxorubicin cardiotoxicity in rats with mammary tumors by dantrolene. (2017)
-
Cervical polyps: Is histologic evaluation necessary? (2016)
Collaboration Network
Top Collaborators
- The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis
- The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis
- Abstract 11421: The M2 Gene is a Determinant of Reovirus-Induced Myocarditis
- The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis
- The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis
- Abstract 11421: The M2 Gene is a Determinant of Reovirus-Induced Myocarditis
- The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis
- The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis
- Abstract 11421: The M2 Gene is a Determinant of Reovirus-Induced Myocarditis
- The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis
- The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis
- Abstract 11421: The M2 Gene is a Determinant of Reovirus-Induced Myocarditis
- The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis
- The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis
- Abstract 11421: The M2 Gene is a Determinant of Reovirus-Induced Myocarditis
- The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis
- The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis
- Abstract 11421: The M2 Gene is a Determinant of Reovirus-Induced Myocarditis
- The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis
- The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis
- The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis
- The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis
- The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis
- The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis
- Abstract 11421: The M2 Gene is a Determinant of Reovirus-Induced Myocarditis
- Abstract 11421: The M2 Gene is a Determinant of Reovirus-Induced Myocarditis
- Clinicopathologic Predictors of Clinical Outcomes in Mammary Adenoid Cystic Carcinoma: A Multi-institutional Study
- Clinicopathologic Predictors of Clinical Outcomes in Mammary Adenoid Cystic Carcinoma: A Multi-institutional Study
- Clinicopathologic Predictors of Clinical Outcomes in Mammary Adenoid Cystic Carcinoma: A Multi-institutional Study
- Clinicopathologic Predictors of Clinical Outcomes in Mammary Adenoid Cystic Carcinoma: A Multi-institutional Study
Similar Researchers
Based on overlapping research topics